p53 as an Effector or Inhibitor of Therapy Response. (Record no. 25514678)

MARC details
000 -LEADER
fixed length control field 01519 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517065535.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201610s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2157-1422
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1101/cshperspect.a026260
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ablain, Julien
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20161005
245 00 - TITLE STATEMENT
Title p53 as an Effector or Inhibitor of Therapy Response.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cold Spring Harbor perspectives in medicine
Date of publication, distribution, etc. Dec 2015
300 ## - PHYSICAL DESCRIPTION
Extent a026260 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arsenic Trioxide
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Arsenicals
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Promyelocytic, Acute
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular Targeted Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncogene Proteins, Fusion
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oxides
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tretinoin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Suppressor Protein p53
General subdivision metabolism
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Poirot, Brigitte
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Esnault, Cécile
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lehmann-Che, Jacqueline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de Thé, Hugues
773 0# - HOST ITEM ENTRY
Title Cold Spring Harbor perspectives in medicine
Related parts vol. 6
-- no. 1
-- p. a026260
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1101/cshperspect.a026260">https://doi.org/10.1101/cshperspect.a026260</a>
Public note Available from publisher's website

No items available.